litlas
Log inCreate account

Beat Thürlimann

Active 1994–2025

75
Papers
28,709
Citations
66
h-index
74
i10-index

Citations

Citations per year for Beat Thürlimann1974: 2 citations1980: 1 citations1981: 1 citations1996: 5 citations1997: 7 citations1998: 9 citations1999: 10 citations2000: 16 citations2001: 39 citations2002: 38 citations2003: 64 citations2004: 74 citations2005: 108 citations2006: 97 citations2007: 140 citations2008: 173 citations2009: 194 citations2010: 176 citations2011: 192 citations2012: 188 citations2013: 216 citations2014: 184 citations2015: 198 citations2016: 217 citations2017: 218 citations2018: 193 citations2019: 733 citations2020: 840 citations2021: 662 citations2022: 544 citations2023: 410 citations2024: 600 citations2025: 259 citations2026: 7 citations1975–1979: no citations, so these years are not shown1982–1995: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,817 citing papers, 18% of this breakdownChina: 970 citing papers, 9.6% of this breakdownItaly: 752 citing papers, 7.5% of this breakdownUnited Kingdom: 656 citing papers, 6.5% of this breakdownGermany: 542 citing papers, 5.4% of this breakdownFrance: 358 citing papers, 3.6% of this breakdownSwitzerland: 342 citing papers, 3.4% of this breakdownCanada: 314 citing papers, 3.1% of this breakdownNetherlands: 307 citing papers, 3.1% of this breakdownBelgium: 302 citing papers, 3% of this breakdownAustralia: 299 citing papers, 3% of this breakdownSpain: 273 citing papers, 2.7% of this breakdown
0%18%Other 31.1%

Institutions

Fields

  • Biochemistry, Genetics and Molecular Biology51.2%
  • Medicine40.7%
  • Computer Science2.4%
  • Immunology and Microbiology1.1%
  • Engineering1%
  • Pharmacology, Toxicology and Pharmaceutics0.7%
  • Other2.9%

Topics

  • Breast Cancer Treatment Studies15.3%
  • Breast Lesions and Carcinomas5.6%
  • HER2/EGFR in Cancer Research4.7%
  • Estrogen and related hormone effects4.5%
  • Advanced Breast Cancer Therapies3.6%
  • Cancer Cells and Metastasis2.5%
  • Other63.8%

Coauthors

All papers

Open in search
  1. Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013

    Authors: Aron Goldhirsch, Eric P. Winer, Alan S. Coates, Richard D. Gelber, Martine Piccart, Beat Thürlimann, Hans-Jörg Senn, Kathy S. Albain, Fabrice André, Jonas Bergh, Hervé Bonnefoi, Denisse Bretel-Morales, Harold J. Burstein, Fátima Cardoso, Monica Castiglione‐Gertsch, Alan S. Coates, Marco Colleoni, Alberto Costa, Giuseppe Curigliano, Nancy E. Davidson, Angelo Di Leo, Bent Ejlertsen, John Forbes, Richard D. Gelber, Michael Gnant, Aron Goldhirsch, Pamela J. Goodwin, Paul E. Goss, Jay R. Harris, Daniel F. Hayes, Clifford A. Hudis, James N. Ingle, Jacek Jassem, Zefei Jiang, Per Karlsson, Sibylle Loibl, Monica Morrow, Moïse Namer, C. Kent Osborne, Ann H. Partridge, Frédérique Penault‐Llorca, Charles M. Perou, Martine Piccart, Kathleen I. Pritchard, Emiel J. Rutgers, Felix Sedlmayer, Semiglazov Vf, Zhi‐Ming Shao, Ian Smith, Beat Thürlimann, Masakazu Toi, Andrew Tutt, Michael Untch, Giuseppe Viale, Toru Watanabe, Nicholas Wilcken, Eric P. Winer, William C. Wood - Annals of Oncology 2013 cited by 3,715

  2. Customizing local and systemic therapies for women with early breast cancer: the St. Gallen International Consensus Guidelines for treatment of early breast cancer 2021

    Authors: Harold J. Burstein, Giuseppe Curigliano, Beat Thürlimann, William P. Weber, Philip Poortmans, Meredith M. Regan, H.-J. Senn, Eric P. Winer, Michael Gnant, Stephan Aebi, Fabrice André, Carlos Barrios, Jonas Bergh, Hervé Bonnefoi, Denisse Bretel Morales, Sara Y. Brucker, Harold J. Burstein, David Cameron, Fátima Cardoso, Lisa A. Carey, Boon Chua, Eva Ciruelos, Marco Colleoni, Giuseppe Curigliano, Suzette Delaloge, Carsten Denkert, Peter Dubsky, Bent Ejlertsen, Florian Fitzal, Prudence A. Francis, Viviana Galimberti, Hebatallah Gamal El Din Mohamed Mahmoud, Judy E. Garber, Michael Gnant, William J. Gradishar, Bahadır M. Güllüoğlu, Nadia Harbeck, Chiun‐Sheng Huang, Jens Huober, André Ilbawi, Zefei Jiang, Steven Johnston, Eun Sook Lee, Sibylle Loibl, Monica Morrow, Ann H. Partridge, Martine Piccart, Philip Poortmans, Aleix Prat, Meredith M. Regan, Isabella Rubio, Hope S. Rugo, Emiel J. Rutgers, Felix Sedlmayer, Vladimir Semiglazov, Hans-Joerg Senn, Zhiming Shao, Tanja Španić, Petra Tesařová, Beat Thürlimann, Sergei Tjulandin, Masakazu Toi, Maureen Trudeau, Nicholas Turner, Inez Vaz Luis, Giuseppe Viale, Toru Watanabe, William P. Weber, Eric P. Winer, Binghe Xu - Annals of Oncology 2021 cited by 803

  3. Strategies for subtypes—dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011

    Authors: Aron Goldhirsch, W. C. Wood, Alan S. Coates, Richard D. Gelber, Beat Thürlimann, Hans-Jörg Senn - Annals of Oncology 2011 cited by 3,881

  4. Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015

    Authors: Alan S. Coates, Eric P. Winer, Aron Goldhirsch, Richard D. Gelber, Michael Gnant, Martine Piccart, Beat Thürlimann, H.-J. Senn, Fabrice André, José Baselga, Jonas Bergh, Hervé Bonnefoi, Harold J. Burstein, Fátima Cardoso, Monica Castiglione‐Gertsch, Alan S. Coates, Marco Colleoni, Giuseppe Curigliano, Nancy E. Davidson, Angelo Di Leo, Bent Ejlertsen, John Forbes, Viviana Galimberti, Richard D. Gelber, Michael Gnant, Aron Goldhirsch, Pamela J. Goodwin, Nadia Harbeck, Daniel F. Hayes, Jens Huober, Clifford A. Hudis, James N. Ingle, Jacek Jassem, Zefei Jiang, Per Karlsson, Monica Morrow, Roberto Orecchia, C. Kent Osborne, Ann H. Partridge, Lorena de la Peña, Martine Piccart, Kathleen I. Pritchard, Emiel J. Rutgers, Felix Sedlmayer, Semiglazov Vf, Zhi‐Ming Shao, Ian Smith, Beat Thürlimann, Masakazu Toi, Andrew Tutt, Giuseppe Viale, Gϋnter von Minckwitz, Toru Watanabe, Timothy J. Whelan, Eric P. Winer, Binghe Xu - Annals of Oncology 2015 cited by 1,837

  5. Understanding breast cancer complexity to improve patient outcomes: The St Gallen International Consensus Conference for the Primary Therapy of Individuals with Early Breast Cancer 2023

    Authors: Giuseppe Curigliano, Harold J. Burstein, Michael Gnant, Sibylle Loibl, David Cameron, Meredith M. Regan, Carsten Denkert, Philip Poortmans, William P. Weber, Beat Thürlimann, Stefan Aebi, Meteb Al‐Foheidi, Fabrice André, Mykola Anikusko, R. Badwe, A.V. Barrio, Carlos H. Barrios, Jonas Bergh, Hervé Bonnefoi, Daniela Morales, Sara Y. Brucker, Harold J. Burstein, Carlos Caldas, David Cameron, F. Cardoso, Maria João Cardoso, L.A Carey, Stephen Chia, Charlotte E. Coles, J. Cortes, Giuseppe Curigliano, Jana de Boniface, Suzette Delaloge, A. DeMichele, Carsten Denkert, Gerd Fastner, Florian Fitzal, Prudence A. Francis, H Gamal, Oreste ­Gentilini, Michael Gnant, William J. Gradishar, B. Gulluoglu, Nadia Harbeck, Jörg Heil, Chien Shiun Huang, Jens Huober, Zeping Jiang, Orit Kaidar‐Person, Marleen Kok, Eun‐So Lee, Sherene Loi, S. Loibl, Miguel Martín, Icro Meattini, Monica Morrow, A. H. Partridge, Frédérique Penault‐Llorca, Martine Piccart, Lori J. Pierce, Philip Poortmans, Meredith M. Regan, J. S. Reis-Filho, Isabel T. Rubio, Hope S. Rugo, Emiel J. Rutgers, Cristina Saura, Elżbieta Senkus, Zhi-Ming Shao, Christian F. Singer, Tanja Španič, Beat Thuerlimann, Masakazu Toi, Sara M. Tolaney, Nicholas C. Turner, Andrew Tutt, M.-J. Vrancken Peeters, Toru Watanabe, William P. Weber, Hans Wildiers, B. Xu - Annals of Oncology 2023 cited by 221

  6. De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017

    Authors: Giuseppe Curigliano, Harold J. Burstein, Eric P. Winer, Michael Gnant, Peter Dubsky, Sibylle Loibl, Marco Colleoni, Meredith M. Regan, Martine Piccart, Hans-Jörg Senn, Beat Thürlimann, Fabrice André, José Baselga, Jonas Bergh, Hervé Bonnefoi, Sara Y. Brucker, Fátima Cardoso, Lisa A. Carey, Eva Ciruelos, Jack Cuzick, Carsten Denkert, Angelo Di Leo, Bent Ejlertsen, Prudence A. Francis, V.E. Galimberti, Judy E. Garber, Bahadır M. Güllüoğlu, Pamela J. Goodwin, Nadia Harbeck, Daniel F. Hayes, Chiun‐Sheng Huang, Jens Huober, Hussein Khaled, Jacek Jassem, Zefei Jiang, Per Karlsson, Monica Morrow, Roberto Orecchia, Kent C. Osborne, Olivia Pagani, Ann H. Partridge, K. Pritchard, Jungsil Ro, Emiel J. Rutgers, Felix Sedlmayer, Semiglazov Vf, Zhi‐Ming Shao, Ian Smith, Masakazu Toi, Andrew Tutt, Giuseppe Viale, Toru Watanabe, Timothy J. Whelan, Binghe Xu - Annals of Oncology 2017 cited by 1,255

  7. Annual Hazard Rates of Recurrence for Breast Cancer During 24 Years of Follow-Up: Results From the International Breast Cancer Study Group Trials I to V

    Authors: Marco Colleoni, Zhuoxin Sun, Karen N. Price, Per Karlsson, John Forbes, Beat Thürlimann, Lorenzo Gianni, Monica Castiglione, Richard D. Gelber, Alan S. Coates, Aron Goldhirsch - Journal of Clinical Oncology 2016 cited by 623

  8. Estimating the benefits of therapy for early-stage breast cancer: the St. Gallen International Consensus Guidelines for the primary therapy of early breast cancer 2019

    Authors: Harold J. Burstein, Giuseppe Curigliano, Sibylle Loibl, Peter Dubsky, Michael Gnant, Philip Poortmans, Marco Colleoni, Carsten Denkert, Martine Piccart, Meredith M. Regan, H.-J. Senn, Eric P. Winer, Beat Thürlimann - Annals of Oncology 2019 cited by 690

  9. Distinct Clinical and Prognostic Features of Infiltrating Lobular Carcinoma of the Breast: Combined Results of 15 International Breast Cancer Study Group Clinical Trials

    Authors: Bernhard C. Pestalozzi, David Zahrieh, Elizabeth Mallon, Barry A. Gusterson, Karen N. Price, Richard D. Gelber, Stig B. Holmberg, Jurij Lindtner, Raymond Snyder, Beat Thürlimann, Elizabeth Murray, Giuseppe Viale, Monica Castiglione‐Gertsch, Alan S. Coates, Aron Goldhirsch - Journal of Clinical Oncology 2008 cited by 497

  10. Treatment Adherence and Its Impact on Disease-Free Survival in the Breast International Group 1-98 Trial of Tamoxifen and Letrozole, Alone and in Sequence

    Authors: Jacquie Chirgwin, Anita Giobbie‐Hurder, Alan S. Coates, Karen N. Price, Bent Ejlertsen, Marc Debled, Richard D. Gelber, Aron Goldhirsch, Ian Smith, Manuela Rabaglio, John Forbes, Patrick Neven, István Láng, Marco Colleoni, Beat Thürlimann - Journal of Clinical Oncology 2016 cited by 253

  11. Integration of Clinical Variables for the Prediction of Late Distant Recurrence in Patients With Estrogen Receptor–Positive Breast Cancer Treated With 5 Years of Endocrine Therapy: CTS5

    Authors: Mitch Dowsett, Ivana Šestak, Meredith M. Regan, Andrew Dodson, Giuseppe Viale, Beat Thürlimann, Marco Colleoni, Jack Cuzick - Journal of Clinical Oncology 2018 cited by 189

  12. Relative Effectiveness of Letrozole Compared With Tamoxifen for Patients With Lobular Carcinoma in the BIG 1-98 Trial

    Authors: Otto Metzger, Anita Giobbie‐Hurder, Elizabeth Mallon, Barry A. Gusterson, Giuseppe Viale, Eric P. Winer, Beat Thürlimann, Richard D. Gelber, Marco Colleoni, Bent Ejlertsen, Marc Debled, Karen N. Price, Meredith M. Regan, Alan S. Coates, Aron Goldhirsch - Journal of Clinical Oncology 2015 cited by 199

  13. Obesity and Risk of Recurrence or Death After Adjuvant Endocrine Therapy With Letrozole or Tamoxifen in the Breast International Group 1-98 Trial

    Authors: Marianne Ewertz, Kathryn P. Gray, Meredith M. Regan, Bent Ejlertsen, Karen N. Price, Beat Thürlimann, Hervé Bonnefoi, John Forbes, Robert Paridaens, Manuela Rabaglio, Richard D. Gelber, Marco Colleoni, István Láng, Ian E. Smith, Alan S. Coates, Aron Goldhirsch, Henning T. Mouridsen - Journal of Clinical Oncology 2012 cited by 133

  14. Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2009

    Authors: Aron Goldhirsch, James N. Ingle, Richard D. Gelber, Alan S. Coates, Beat Thürlimann, Hans-Jörg Senn - Annals of Oncology 2009 cited by 1,370

  15. Assessment of letrozole and tamoxifen alone and in sequence for postmenopausal women with steroid hormone receptor-positive breast cancer: the BIG 1-98 randomised clinical trial at 8·1 years median follow-up

    Authors: Meredith M. Regan, Patrick Neven, Anita Giobbie‐Hurder, Aron Goldhirsch, Bent Ejlertsen, L. Mauriac, John Forbes, Ian Smith, István Láng, Andrew Wardley, Manuela Rabaglio, Karen N. Price, Richard D. Gelber, Alan S. Coates, Beat Thürlimann - The Lancet Oncology 2011 cited by 408

  16. Chemotherapy for isolated locoregional recurrence of breast cancer (CALOR): a randomised trial

    Authors: Stefan Aebi, Shari Gelber, Stewart Anderson, István Láng, André Robidoux, Miguel Martín, J.W.R. Nortier, Alexander Paterson, Mothaffar F. Rimawi, José Manuel Baena Cañada, Beat Thürlimann, Elizabeth Murray, Eleftherios P. Mamounas, Charles E. Geyer, Karen N. Price, Alan S. Coates, Richard D. Gelber, Priya Rastogi, Norman Wolmark, Irene Wapnir - The Lancet Oncology 2014 cited by 206

  17. Prognostic and predictive value of androgen receptor expression in postmenopausal women with estrogen receptor-positive breast cancer: results from the Breast International Group Trial 1–98

    Authors: Kevin H. Kensler, Meredith M. Regan, Yujing J. Heng, Gabrielle M. Baker, Michael E. Pyle, Stuart J. Schnitt, Aditi Hazra, Roswitha Kammler, Beat Thürlimann, Marco Colleoni, Giuseppe Viale, Myles Brown, Rulla M. Tamimi - Breast Cancer Research 2019 cited by 148

  18. Cholesterol, Cholesterol-Lowering Medication Use, and Breast Cancer Outcome in the BIG 1-98 Study

    Authors: Signe Borgquist, Anita Giobbie‐Hurder, Thomas P. Ahern, Judy E. Garber, Marco Colleoni, István Láng, Marc Debled, Bent Ejlertsen, Roger von Moos, Ian C. P. Smith, Alan S. Coates, Aron Goldhirsch, Manuela Rabaglio, Karen N. Price, Richard D. Gelber, Meredith M. Regan, Beat Thürlimann - Journal of Clinical Oncology 2017 cited by 136

  19. Genomic characterisation of hormone receptor-positive breast cancer arising in very young women

    Authors: Stephen J. Luen, Giuseppe Viale, Serena Nik‐Zainal, Peter Savas, Roswitha Kammler, Patrizia Dell’Orto, Olivia Biasi, Andrea Degasperi, L.C. Brown, István Láng, Gaëtan MacGrogan, Carlo Tondini, Meritxell Bellet, Federica Villa, Antônio Bernardo, Eva Ciruelos, Per Karlsson, Patrick Neven, José A. Martinez‐Climent, Bettina Müller, Wolfram Jochum, Hervé Bonnefoi, Silvana Martino, Nancy E. Davidson, Charles E. Geyer, Stephen Chia, James N. Ingle, Robert L. Coleman, Christine Solbach, Beat Thürlimann, Marco Colleoni, Alan S. Coates, Aron Goldhirsch, Gini F. Fleming, Prudence A. Francis, Terence P. Speed, Meredith M. Regan, Sherene Loi - Annals of Oncology 2023 cited by 48

  20. Prognostic and Predictive Value of Centrally Reviewed Expression of Estrogen and Progesterone Receptors in a Randomized Trial Comparing Letrozole and Tamoxifen Adjuvant Therapy for Postmenopausal Early Breast Cancer: BIG 1-98

    Authors: Giuseppe Viale, Meredith M. Regan, Eugenio Maiorano, Mauro G. Mastropasqua, Patrizia Dell’Orto, Birgitte Rasmussen, Johnny Raffoul, Patrick Neven, Zsolt Orosz, Stephen Braye, Christian Öhlschlegel, Beat Thürlimann, Richard D. Gelber, Monica Castiglione‐Gertsch, Karen N. Price, Aron Goldhirsch, Barry A. Gusterson, Alan S. Coates - Journal of Clinical Oncology 2007 cited by 456

  21. The multidisciplinary meeting: An indispensable aid to communication between different specialities

    Authors: Thomas Ruhstaller, Helen Roe, Beat Thürlimann, J. J. Nicoll - European Journal of Cancer 2006 cited by 297

  22. Bone fractures among postmenopausal patients with endocrine-responsive early breast cancer treated with 5 years of letrozole or tamoxifen in the BIG 1-98 trial

    Authors: Manuela Rabaglio, Zijie Sun, Karen N. Price, Monica Castiglione‐Gertsch, Hanne Hawle, Beat Thürlimann, Henning T. Mouridsen, Mario Campone, JF Forbes, Robert Paridaens, Marco Colleoni, Tadeusz Pieńkowski, Jean‐Marie Nogaret, István Láng, Ian Smith, Richard D. Gelber, Aron Goldhirsch, Alan S. Coates - Annals of Oncology 2009 cited by 185

  23. Efficacy of Chemotherapy for ER-Negative and ER-Positive Isolated Locoregional Recurrence of Breast Cancer: Final Analysis of the CALOR Trial

    Authors: Irene Wapnir, Karen N. Price, Stewart Anderson, André Robidoux, Miguel Martín, J.W.R. Nortier, Alexander Paterson, Mothaffar F. Rimawi, István Láng, José Manuel Baena-Cañada, Beat Thürlimann, Eleftherios P. Mamounas, Charles E. Geyer, Shari Gelber, Alan S. Coates, Richard D. Gelber, Priya Rastogi, Meredith M. Regan, Norman Wolmark, Stefan Aebi, on behalf of the International Breast Cancer Study Group, NRG Oncology, GEICAM Spanish Breast Cancer Group, BOOG Dutch Breast Cancer Trialists' Group, Breast International Group - Journal of Clinical Oncology 2018 cited by 167

  24. Low-Dose Oral Cyclophosphamide and Methotrexate Maintenance for Hormone Receptor–Negative Early Breast Cancer: International Breast Cancer Study Group Trial 22-00

    Authors: Marco Colleoni, Kathryn P. Gray, Shari Gelber, István Láng, Beat Thürlimann, Lorenzo Gianni, Ehtesham Abdi, Henry Gómez, Barbro Linderholm, Fabio Puglisi, Carlo Tondini, Elena Kralidis, Alexandru Eniu, Katia Cagossi, Daniel Rauch, Jacquie Chirgwin, Richard D. Gelber, Meredith M. Regan, Alan S. Coates, Karen N. Price, Giuseppe Viale, Aron Goldhirsch - Journal of Clinical Oncology 2016 cited by 76